Current report filing

REVENUES (Details 2)

v3.19.2
REVENUES (Details 2) - Sales Revenue, Net [Member] - Customer Concentration Risk [Member]
3 Months Ended 6 Months Ended
Jun. 30, 2019
Jun. 30, 2018
Jun. 30, 2019
Jun. 30, 2018
AmerisourceBergen Specialty Group [Member]        
Entity Wide Revenue Major Customer [Line Items]        
Concentration risk, percentage 61.00% 89.00% 61.00% 88.00%
McKesson Plasma and Biologics LLC [Member]        
Entity Wide Revenue Major Customer [Line Items]        
Concentration risk, percentage 23.00%   20.00%